-
Kooij wins Tour de France 5th stage in chaotic sprint finish
-
France lose appeal against Olise booking at World Cup
-
Trump says Ukraine can make Patriot missiles
-
Putellas joins star cast at London City Lionesses
-
Teenager arrested after two girls wounded in Germany school attack
-
Oil back at $80, stocks slide as Trump says Iran ceasefire over
-
Farage vs Count Binface: hard-right leader's UK poll gambit
-
Vast crowds mourn Khamenei in Iraq's holy cities
-
Hong Kong's Robert Wun: the bold Millennial conquering Haute Couture
-
Uber Eats, Deliveroo say will give France drivers break when too hot
-
IMF cuts 2026 world growth forecast, flags risks from new Mideast fighting
-
Trump tempers fury to end NATO summit on high note
-
Kostyuk sets up Wimbledon semi-final against Noskova
-
Oil shoots back up, stocks slide as Trump says Iran ceasefire over
-
Noskova reaches first Wimbledon semi-final
-
Kostyuk powers into second straight Slam semi-final at Wimbledon
-
Air Canada taps new CEO to replace chief who couldn't speak French
-
Israeli jails a 'graveyard,' says freed Palestinian journalist
-
Istanbul mayor ejected from court in corruption case
-
Family of last woman executed in UK wins posthumous pardon
-
Landslide kills eight at refugee school in Bangladesh
-
'Serial killer' German doctor given life sentence for 15 murders
-
Cleary leads NSW past Queensland to regain State of Origin crown
-
What is going on with Farage's UK election gambit?
-
MEXC Adds Nine Ondo Tokenized Stock and ETF Trading Pairs Tied to AI Infrastructure Demand
-
Dalic quits after 'incredible era' as Croatia coach
-
Oil prices surge, stocks slide as Trump says Iran ceasefire over
-
Bayeux tapestry to arrive in London in secret, high-stakes operation
-
Sunken wrecks, hot seas threaten fishermen on Italian isle
-
Messi World Cup magic masks familiar penalty frailty
-
Rescuers search for survivors of China storms as super typhoon nears
-
Trump lashes out at allies as key NATO summit begins
-
Egypt file complaint against referee after controversial World Cup exit
-
Swiss party into the night after reaching World Cup quarter-finals
-
Apple loses challenge against EU digital competition rules
-
Trump says Iran ceasefire 'over' after fighting flares
-
Trump says Iran ceasefire 'is over'
-
Thai beer dynasty mother drops 'ungrateful child' case against son
-
Rescuers search for missing in China storms after 100,000 flee
-
France v Morocco rematch as World Cup quarter-finals get under way
-
OpenAI to launch new model after US freeze
-
Modi visits Australia for minerals talks and rockstar welcome
-
UK museums at 'sharp end' of climate change challenge
-
Sensors, early starts: how Spain keeps working when heat hits
-
In Mauritania, Imraguen people's desert-ocean paradise under threat
-
Kenya Rastafarians hope for freedom to smoke
-
Iraq's holy cities host funeral processions for Khamenei
-
Pacific nation of Tuvalu condemns Chinese missile launch into Pacific
-
Rescuers search for missing in China storms after 100,000 evacuated
-
How a viral post sparked India's Gen-Z protest
Google AI tool predicts danger of genetic mutations
Researchers at Google DeepMind, the tech giant's artificial intelligence arm, on Tuesday introduced a tool that predicts whether genetic mutations are likely to cause harm, a breakthrough that could help research into rare diseases.
The findings are "another step in recognising the impact that AI is having in the natural sciences," said Pushmeet Kohli, vice president for research at Google DeepMind.
The tool focuses on so-called "missense" mutations, where a single letter of the genetic code is affected.
A typical human has 9,000 such mutations throughout their genome; they can be harmless or cause diseases such as cystic fibrosis or cancer, or damage brain development.
To date, four million of these mutations have been observed in humans, but only two percent of them have been classified, either as disease-causing or benign.
In all, there are 71 million such possible mutations. The Google DeepMind tool, called AlphaMissense, reviewed these mutations and was able to predict 89 percent of them, with 90 percent accuracy.
A score was assigned to each mutation, indicating the risk of it causing disease (otherwise referred to as pathogenic).
The result: 57 percent were classified as probably benign, and 32 percent as probably pathogenic -- the remainder being uncertain.
The database was made public and available to scientists, and an accompanying study was published on Tuesday in the journal Science.
AlphaMissense demonstrates "superior performance" than previously available tools, wrote experts Joseph Marsh and Sarah Teichmann in an article also published in Science.
"We should emphasize that the predictions were never really trained or never really intended to be used for clinical diagnosis alone," said Jun Cheng of Google DeepMind.
"However, we do think that our predictions can potentially be helpful to increase the diagnosed rate of rare disease, and also potentially to help us find new disease-causing genes," Cheng added.
Indirectly, this could lead to the development of new treatments, the researchers said.
The tool was trained on the DNA of humans and closely-related primates, enabling it to recognize which genetic mutations are widespread.
Cheng said the training allowed the tool to input "millions of protein sequences and learns what a regular protein sequence looks like."
It then could identify a mutation and its potential for harm.
Cheng compared the process to learning a language.
"If we substitute a word from an English sentence, a person that is familiar with English can immediately see whether this word substitution will change the meaning of the sentence or not."
H.Gonzales--AT